Related Experiment Video
Updated: Aug 2, 2026

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
Published on: August 12, 2017
Hemolytic uremic syndrome after multivisceral transplantation treated with intravenous immunoglobulin
Debasish Banerjee1, Warren Kupin, David Roth
1Division of Nephrology and Transplantation, University of Miami, Miami, Florida 33136, USA.
Post transplant hemolytic uremic syndrome (HUS) secondary to immunosuppressive regimen is becoming more common with increasing numbers of organ transplantation. We describe a case of refractory HUS secondary to immunosuppression post multivisceral transplantation, successfully managed with plasmapheresis and intravenous immunoglobulin (IVIG).
Post transplant hemolytic uremic syndrome (HUS) secondary to immunosuppressive regimen is becoming more common with increasing numbers of organ transplantation. We describe a case of refractory HUS secondary to immunosuppression post multivisceral transplantation, successfully managed with plasmapheresis and intravenous immunoglobulin (IVIG).
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management

